NEW DELHI: In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic acid (sHA) gel during radiation treatment for gynaecological cancers.
The gel is already approved by Australia's Therapeutic Goods Administration for use in prostate cancer radiation treatment.
The team led by experts from Monash University investigated hyaluronic acid gel for the first time in women as a means to gently create more space between the tumour and the rectum during MRI-guided brachytherapy -- a type of internal radiation treatment.